BridgeBio scraps plan to buy Eidos after bids rebuffed

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Oct 14, 2019 at 10:12 AM.

  1. #1 cafead, Oct 14, 2019 at 10:12 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,056
    Likes Received:
    3
    via BridgeBio Pharma has scrapped plans to buy out its subsidiary Eidos Therapeutics. The planned deal hit a wall when a special committee set up by Eidos turned down BridgeBio’s third and final offer.

    article source
     
    Quote

Reply to Thread